Significance of PRDM1beta expression as a prognostic marker in diffuse large B-cell lymphomas

Blood. 2008 Feb 15;111(4):2488-9; author reply 2489-90. doi: 10.1182/blood-2007-09-111385.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Humans
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics*
  • Positive Regulatory Domain I-Binding Factor 1
  • Prognosis
  • Repressor Proteins / genetics*
  • Transcription Factors / genetics*

Substances

  • Repressor Proteins
  • Transcription Factors
  • PRDM1 protein, human
  • Positive Regulatory Domain I-Binding Factor 1